BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37650501)

  • 21. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
    Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.
    Sheng G; Lu S; Xie Q; Peng N; Kuang M; Zou Y
    Lipids Health Dis; 2021 Oct; 20(1):134. PubMed ID: 34629059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study.
    Fresneda S; Abbate M; Busquets-Cortés C; López-González A; Fuster-Parra P; Bennasar-Veny M; Yáñez AM
    Biol Sex Differ; 2022 Nov; 13(1):64. PubMed ID: 36333736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Goulart AC; Oliveira IR; Alencar AP; Santos MS; Santos IS; Martines BM; Meireles DP; Martines JA; Misciagna G; Benseñor IM; Lotufo PA
    Sao Paulo Med J; 2015; 133(2):115-24. PubMed ID: 26018881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.
    Wang C; Cai Z; Deng X; Li H; Zhao Z; Guo C; Zhang P; Li L; Gu T; Yang L; Zhao L; Wang D; Yuan G
    Int J Med Sci; 2021; 18(14):3280-3289. PubMed ID: 34400897
    [No Abstract]   [Full Text] [Related]  

  • 27. Population-specific cut-off points of fatty liver index: a study based on the National Health and Nutrition Examination Survey data.
    Wu J; Tian S; Li H; Xu Z; Li S; Chen YL; Liang XY; Xiao J; Song JY; She RL; Ma CY; Feng JH; Li ZX; Jiang ZY; Zhang ZW; Wu KN; Kong LQ
    BMC Gastroenterol; 2022 May; 22(1):265. PubMed ID: 35624410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran.
    Motamed N; Faraji AH; Khonsari MR; Maadi M; Tameshkel FS; Keyvani H; Ajdarkosh H; Karbalaie Niya MH; Rezaie N; Zamani F
    Clin Nutr; 2020 Feb; 39(2):468-474. PubMed ID: 30922791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of simple indexes for nonalcoholic fatty liver disease in western China: a retrospective cross-sectional study.
    Zhu J; He M; Zhang Y; Li T; Liu Y; Xu Z; Chen W
    Endocr J; 2018 Mar; 65(3):373-381. PubMed ID: 29434074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body composition, phenotype and central obesity indices in Egyptian women with non-alcoholic fatty liver disease.
    Zaki M; Amin D; Mohamed R
    J Complement Integr Med; 2020 Dec; 18(2):385-390. PubMed ID: 34187121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatty liver index as a simple predictor of incident diabetes from the KoGES-ARIRANG study.
    Yadav D; Choi E; Ahn SV; Koh SB; Sung KC; Kim JY; Huh JH
    Medicine (Baltimore); 2016 Aug; 95(31):e4447. PubMed ID: 27495073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes.
    Giorda C; Forlani G; Manti R; Mazzella N; De Cosmo S; Rossi MC; Nicolucci A; Russo G; Di Bartolo P; Ceriello A; Guida P;
    Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 28032449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study.
    Park JH; Choi IS; Han KD; Park H; Kim KH; Kim JS
    Clin Breast Cancer; 2020 Aug; 20(4):e450-e457. PubMed ID: 32192863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease.
    Xia MF; Yki-Järvinen H; Bian H; Lin HD; Yan HM; Chang XX; Zhou Y; Gao X
    PLoS One; 2016; 11(8):e0160526. PubMed ID: 27579785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population.
    Hu H; Han Y; Cao C; He Y
    J Transl Med; 2022 Sep; 20(1):398. PubMed ID: 36064712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical risk scoring for predicting non-alcoholic fatty liver disease in metabolic syndrome patients (NAFLD-MS score).
    Saokaew S; Kanchanasuwan S; Apisarnthanarak P; Charoensak A; Charatcharoenwitthaya P; Phisalprapa P; Chaiyakunapruk N
    Liver Int; 2017 Oct; 37(10):1535-1543. PubMed ID: 28294515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Usefulness of Neck Circumference, Waist-to-Height Ratio and Waist-to-Hip Ratio in Predicting Non-Alcoholic Fatty Liver Disease in Saudi Population Without Type 2 Diabetes.
    Alqahtani S; Al-Raddadi R; Ajabnoor G; Alraddadi Z; Alahmadi J; Alhabash A; Hakim R; Alseraihi L; Bahijri S
    Nutr Metab Insights; 2024; 17():11786388241259942. PubMed ID: 38911904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic value of alcoholic liver disease (ALD)/nonalcoholic fatty liver disease (NAFLD) index combined with γ-glutamyl transferase in differentiating ALD and NAFLD.
    Wang J; Li P; Jiang Z; Yang Q; Mi Y; Liu Y; Shi R; Zhou Y; Wang J; Lu W; Li S; Liu D
    Korean J Intern Med; 2016 May; 31(3):479-87. PubMed ID: 27025268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-resolution of non-alcoholic fatty liver disease (NAFLD) among urban, adult Sri Lankans in the general population: A prospective, cohort follow-up study.
    Niriella MA; Kasturiratna A; Beddage T; Ediriweera DS; De Silva ST; Perera KR; Subasinghe CE; Kodisinghe SK; Piyaratna TC; Rishikesawan V; Dassanayaka AS; De Silva AP; Pathmeswaran A; Wickramasinghe AR; Kato N; Janaka de Silva H
    PLoS One; 2019; 14(10):e0224474. PubMed ID: 31661524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.